Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture

Minoti Sharma, David E. Shubert, Moheswar Sharma, Kerry J. Rodabaugh, Barbara P. McGarrigle, Chad M. Vezina, Diane P. Bofinger, James R. Olson

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Fresh human endometrial explants were incubated for 24h at 37°C with either tamoxifen (10-100μM) or the vehicle (0.1% ethanol). Three metabolites namely, α-hydroxytamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen were identified in the culture media. Tissue size was limited but DNA adducts formed by the α-hydroxytamoxifen pathway were detected using authentic α-(deoxyguanosyl-N2) tamoxifen standards. Relative DNA-adduct levels of 2.45, 1.12, and 0.44 per 106 nucleotides were detected following incubations with 100, 25, and 10μM tamoxifen, respectively. The concurrent exposure of the explants to 100μM tamoxifen with 1mM ascorbic acid reduced the level of α-hydroxytamoxifen substantially (68.9%). The formation of tamoxifen-DNA adducts detectable in the explants from the same specimens exposed to 100μM tamoxifen with 1mM ascorbic acid were also inhibited. These results support the role of oxidative biotransformation of tamoxifen in the subsequent formation of DNA adducts in this tissue.

Original languageEnglish (US)
Pages (from-to)157-164
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume307
Issue number1
DOIs
StatePublished - Jul 18 2003

Fingerprint

DNA Adducts
Tamoxifen
Antioxidants
Ascorbic Acid
Tissue
Biotransformation
Metabolites
Culture Media
Ethanol
Nucleotides
hydroxytamoxifen

Keywords

  • Antioxidant
  • Explant culture
  • Human endometrial tissue
  • Tamoxifen metabolites
  • Tamoxifen-DNA adducts

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture. / Sharma, Minoti; Shubert, David E.; Sharma, Moheswar; Rodabaugh, Kerry J.; McGarrigle, Barbara P.; Vezina, Chad M.; Bofinger, Diane P.; Olson, James R.

In: Biochemical and Biophysical Research Communications, Vol. 307, No. 1, 18.07.2003, p. 157-164.

Research output: Contribution to journalArticle

Sharma, M, Shubert, DE, Sharma, M, Rodabaugh, KJ, McGarrigle, BP, Vezina, CM, Bofinger, DP & Olson, JR 2003, 'Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture', Biochemical and Biophysical Research Communications, vol. 307, no. 1, pp. 157-164. https://doi.org/10.1016/S0006-291X(03)01134-3
Sharma, Minoti ; Shubert, David E. ; Sharma, Moheswar ; Rodabaugh, Kerry J. ; McGarrigle, Barbara P. ; Vezina, Chad M. ; Bofinger, Diane P. ; Olson, James R. / Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture. In: Biochemical and Biophysical Research Communications. 2003 ; Vol. 307, No. 1. pp. 157-164.
@article{e2fd6d69afdb445bad95e832dcd405ff,
title = "Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture",
abstract = "Fresh human endometrial explants were incubated for 24h at 37°C with either tamoxifen (10-100μM) or the vehicle (0.1{\%} ethanol). Three metabolites namely, α-hydroxytamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen were identified in the culture media. Tissue size was limited but DNA adducts formed by the α-hydroxytamoxifen pathway were detected using authentic α-(deoxyguanosyl-N2) tamoxifen standards. Relative DNA-adduct levels of 2.45, 1.12, and 0.44 per 106 nucleotides were detected following incubations with 100, 25, and 10μM tamoxifen, respectively. The concurrent exposure of the explants to 100μM tamoxifen with 1mM ascorbic acid reduced the level of α-hydroxytamoxifen substantially (68.9{\%}). The formation of tamoxifen-DNA adducts detectable in the explants from the same specimens exposed to 100μM tamoxifen with 1mM ascorbic acid were also inhibited. These results support the role of oxidative biotransformation of tamoxifen in the subsequent formation of DNA adducts in this tissue.",
keywords = "Antioxidant, Explant culture, Human endometrial tissue, Tamoxifen metabolites, Tamoxifen-DNA adducts",
author = "Minoti Sharma and Shubert, {David E.} and Moheswar Sharma and Rodabaugh, {Kerry J.} and McGarrigle, {Barbara P.} and Vezina, {Chad M.} and Bofinger, {Diane P.} and Olson, {James R.}",
year = "2003",
month = "7",
day = "18",
doi = "10.1016/S0006-291X(03)01134-3",
language = "English (US)",
volume = "307",
pages = "157--164",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Antioxidant inhibits tamoxifen-DNA adducts in endometrial explant culture

AU - Sharma, Minoti

AU - Shubert, David E.

AU - Sharma, Moheswar

AU - Rodabaugh, Kerry J.

AU - McGarrigle, Barbara P.

AU - Vezina, Chad M.

AU - Bofinger, Diane P.

AU - Olson, James R.

PY - 2003/7/18

Y1 - 2003/7/18

N2 - Fresh human endometrial explants were incubated for 24h at 37°C with either tamoxifen (10-100μM) or the vehicle (0.1% ethanol). Three metabolites namely, α-hydroxytamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen were identified in the culture media. Tissue size was limited but DNA adducts formed by the α-hydroxytamoxifen pathway were detected using authentic α-(deoxyguanosyl-N2) tamoxifen standards. Relative DNA-adduct levels of 2.45, 1.12, and 0.44 per 106 nucleotides were detected following incubations with 100, 25, and 10μM tamoxifen, respectively. The concurrent exposure of the explants to 100μM tamoxifen with 1mM ascorbic acid reduced the level of α-hydroxytamoxifen substantially (68.9%). The formation of tamoxifen-DNA adducts detectable in the explants from the same specimens exposed to 100μM tamoxifen with 1mM ascorbic acid were also inhibited. These results support the role of oxidative biotransformation of tamoxifen in the subsequent formation of DNA adducts in this tissue.

AB - Fresh human endometrial explants were incubated for 24h at 37°C with either tamoxifen (10-100μM) or the vehicle (0.1% ethanol). Three metabolites namely, α-hydroxytamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen were identified in the culture media. Tissue size was limited but DNA adducts formed by the α-hydroxytamoxifen pathway were detected using authentic α-(deoxyguanosyl-N2) tamoxifen standards. Relative DNA-adduct levels of 2.45, 1.12, and 0.44 per 106 nucleotides were detected following incubations with 100, 25, and 10μM tamoxifen, respectively. The concurrent exposure of the explants to 100μM tamoxifen with 1mM ascorbic acid reduced the level of α-hydroxytamoxifen substantially (68.9%). The formation of tamoxifen-DNA adducts detectable in the explants from the same specimens exposed to 100μM tamoxifen with 1mM ascorbic acid were also inhibited. These results support the role of oxidative biotransformation of tamoxifen in the subsequent formation of DNA adducts in this tissue.

KW - Antioxidant

KW - Explant culture

KW - Human endometrial tissue

KW - Tamoxifen metabolites

KW - Tamoxifen-DNA adducts

UR - http://www.scopus.com/inward/record.url?scp=0038387788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038387788&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(03)01134-3

DO - 10.1016/S0006-291X(03)01134-3

M3 - Article

C2 - 12849995

AN - SCOPUS:0038387788

VL - 307

SP - 157

EP - 164

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -